Interleukin 17A Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Interleukin 17A in global, including the following market information:
Global Interleukin 17A Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Interleukin 17A Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Interleukin 17A companies in 2021 (%)
The global Interleukin 17A market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ABY-035 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interleukin 17A manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interleukin 17A Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, by Type, 2021 (%)
Global Interleukin 17A Market Segment Percentages, by Application, 2021 (%)
Global Interleukin 17A Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Interleukin 17A revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Interleukin 17A revenues share in global market, 2021 (%)
Key companies Interleukin 17A sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Interleukin 17A sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Interleukin 17A Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Interleukin 17A Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Interleukin 17A companies in 2021 (%)
The global Interleukin 17A market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ABY-035 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interleukin 17A manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interleukin 17A Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, by Type, 2021 (%)
- ABY-035
- CNTO-6785
- DLX-2882
- Others
Global Interleukin 17A Market Segment Percentages, by Application, 2021 (%)
- Chronic Pain
- Liver Cancer
- Kidney Cancer
- Others
Global Interleukin 17A Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Interleukin 17A revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Interleukin 17A revenues share in global market, 2021 (%)
Key companies Interleukin 17A sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Interleukin 17A sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie Inc
- Abeome Corporation
- Affibody AB
- Cell Medica Limited
- Eli Lilly and Company
- Johnson & Johnson
- Merck KGaA
- Novartis AG
- Orega Biotech SAS
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Interleukin 17A Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Interleukin 17A Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INTERLEUKIN 17A OVERALL MARKET SIZE
2.1 Global Interleukin 17A Market Size: 2021 VS 2028
2.2 Global Interleukin 17A Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Interleukin 17A Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Interleukin 17A Players in Global Market
3.2 Top Global Interleukin 17A Companies Ranked by Revenue
3.3 Global Interleukin 17A Revenue by Companies
3.4 Global Interleukin 17A Sales by Companies
3.5 Global Interleukin 17A Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Interleukin 17A Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Interleukin 17A Product Type
3.8 Tier 1, Tier 2 and Tier 3 Interleukin 17A Players in Global Market
3.8.1 List of Global Tier 1 Interleukin 17A Companies
3.8.2 List of Global Tier 2 and Tier 3 Interleukin 17A Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Interleukin 17A Market Size Markets, 2021 & 2028
4.1.2 ABY-035
4.1.3 CNTO-6785
4.1.4 DLX-2882
4.1.5 Others
4.2 By Type - Global Interleukin 17A Revenue & Forecasts
4.2.1 By Type - Global Interleukin 17A Revenue, 2017-2022
4.2.2 By Type - Global Interleukin 17A Revenue, 2023-2028
4.2.3 By Type - Global Interleukin 17A Revenue Market Share, 2017-2028
4.3 By Type - Global Interleukin 17A Sales & Forecasts
4.3.1 By Type - Global Interleukin 17A Sales, 2017-2022
4.3.2 By Type - Global Interleukin 17A Sales, 2023-2028
4.3.3 By Type - Global Interleukin 17A Sales Market Share, 2017-2028
4.4 By Type - Global Interleukin 17A Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Interleukin 17A Market Size, 2021 & 2028
5.1.2 Chronic Pain
5.1.3 Liver Cancer
5.1.4 Kidney Cancer
5.1.5 Others
5.2 By Application - Global Interleukin 17A Revenue & Forecasts
5.2.1 By Application - Global Interleukin 17A Revenue, 2017-2022
5.2.2 By Application - Global Interleukin 17A Revenue, 2023-2028
5.2.3 By Application - Global Interleukin 17A Revenue Market Share, 2017-2028
5.3 By Application - Global Interleukin 17A Sales & Forecasts
5.3.1 By Application - Global Interleukin 17A Sales, 2017-2022
5.3.2 By Application - Global Interleukin 17A Sales, 2023-2028
5.3.3 By Application - Global Interleukin 17A Sales Market Share, 2017-2028
5.4 By Application - Global Interleukin 17A Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Interleukin 17A Market Size, 2021 & 2028
6.2 By Region - Global Interleukin 17A Revenue & Forecasts
6.2.1 By Region - Global Interleukin 17A Revenue, 2017-2022
6.2.2 By Region - Global Interleukin 17A Revenue, 2023-2028
6.2.3 By Region - Global Interleukin 17A Revenue Market Share, 2017-2028
6.3 By Region - Global Interleukin 17A Sales & Forecasts
6.3.1 By Region - Global Interleukin 17A Sales, 2017-2022
6.3.2 By Region - Global Interleukin 17A Sales, 2023-2028
6.3.3 By Region - Global Interleukin 17A Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Interleukin 17A Revenue, 2017-2028
6.4.2 By Country - North America Interleukin 17A Sales, 2017-2028
6.4.3 US Interleukin 17A Market Size, 2017-2028
6.4.4 Canada Interleukin 17A Market Size, 2017-2028
6.4.5 Mexico Interleukin 17A Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Interleukin 17A Revenue, 2017-2028
6.5.2 By Country - Europe Interleukin 17A Sales, 2017-2028
6.5.3 Germany Interleukin 17A Market Size, 2017-2028
6.5.4 France Interleukin 17A Market Size, 2017-2028
6.5.5 U.K. Interleukin 17A Market Size, 2017-2028
6.5.6 Italy Interleukin 17A Market Size, 2017-2028
6.5.7 Russia Interleukin 17A Market Size, 2017-2028
6.5.8 Nordic Countries Interleukin 17A Market Size, 2017-2028
6.5.9 Benelux Interleukin 17A Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Interleukin 17A Revenue, 2017-2028
6.6.2 By Region - Asia Interleukin 17A Sales, 2017-2028
6.6.3 China Interleukin 17A Market Size, 2017-2028
6.6.4 Japan Interleukin 17A Market Size, 2017-2028
6.6.5 South Korea Interleukin 17A Market Size, 2017-2028
6.6.6 Southeast Asia Interleukin 17A Market Size, 2017-2028
6.6.7 India Interleukin 17A Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Interleukin 17A Revenue, 2017-2028
6.7.2 By Country - South America Interleukin 17A Sales, 2017-2028
6.7.3 Brazil Interleukin 17A Market Size, 2017-2028
6.7.4 Argentina Interleukin 17A Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Interleukin 17A Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Interleukin 17A Sales, 2017-2028
6.8.3 Turkey Interleukin 17A Market Size, 2017-2028
6.8.4 Israel Interleukin 17A Market Size, 2017-2028
6.8.5 Saudi Arabia Interleukin 17A Market Size, 2017-2028
6.8.6 UAE Interleukin 17A Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AbbVie Inc
7.1.1 AbbVie Inc Corporate Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Interleukin 17A Major Product Offerings
7.1.4 AbbVie Inc Interleukin 17A Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Inc Key News
7.2 Abeome Corporation
7.2.1 Abeome Corporation Corporate Summary
7.2.2 Abeome Corporation Business Overview
7.2.3 Abeome Corporation Interleukin 17A Major Product Offerings
7.2.4 Abeome Corporation Interleukin 17A Sales and Revenue in Global (2017-2022)
7.2.5 Abeome Corporation Key News
7.3 Affibody AB
7.3.1 Affibody AB Corporate Summary
7.3.2 Affibody AB Business Overview
7.3.3 Affibody AB Interleukin 17A Major Product Offerings
7.3.4 Affibody AB Interleukin 17A Sales and Revenue in Global (2017-2022)
7.3.5 Affibody AB Key News
7.4 Cell Medica Limited
7.4.1 Cell Medica Limited Corporate Summary
7.4.2 Cell Medica Limited Business Overview
7.4.3 Cell Medica Limited Interleukin 17A Major Product Offerings
7.4.4 Cell Medica Limited Interleukin 17A Sales and Revenue in Global (2017-2022)
7.4.5 Cell Medica Limited Key News
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Corporate Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Interleukin 17A Major Product Offerings
7.5.4 Eli Lilly and Company Interleukin 17A Sales and Revenue in Global (2017-2022)
7.5.5 Eli Lilly and Company Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Interleukin 17A Major Product Offerings
7.6.4 Johnson & Johnson Interleukin 17A Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Merck KGaA
7.7.1 Merck KGaA Corporate Summary
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Interleukin 17A Major Product Offerings
7.7.4 Merck KGaA Interleukin 17A Sales and Revenue in Global (2017-2022)
7.7.5 Merck KGaA Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Interleukin 17A Major Product Offerings
7.8.4 Novartis AG Interleukin 17A Sales and Revenue in Global (2017-2022)
7.8.5 Novartis AG Key News
7.9 Orega Biotech SAS
7.9.1 Orega Biotech SAS Corporate Summary
7.9.2 Orega Biotech SAS Business Overview
7.9.3 Orega Biotech SAS Interleukin 17A Major Product Offerings
7.9.4 Orega Biotech SAS Interleukin 17A Sales and Revenue in Global (2017-2022)
7.9.5 Orega Biotech SAS Key News
8 GLOBAL INTERLEUKIN 17A PRODUCTION CAPACITY, ANALYSIS
8.1 Global Interleukin 17A Production Capacity, 2017-2028
8.2 Interleukin 17A Production Capacity of Key Manufacturers in Global Market
8.3 Global Interleukin 17A Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INTERLEUKIN 17A SUPPLY CHAIN ANALYSIS
10.1 Interleukin 17A Industry Value Chain
10.2 Interleukin 17A Upstream Market
10.3 Interleukin 17A Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Interleukin 17A Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Interleukin 17A Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Interleukin 17A Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INTERLEUKIN 17A OVERALL MARKET SIZE
2.1 Global Interleukin 17A Market Size: 2021 VS 2028
2.2 Global Interleukin 17A Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Interleukin 17A Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Interleukin 17A Players in Global Market
3.2 Top Global Interleukin 17A Companies Ranked by Revenue
3.3 Global Interleukin 17A Revenue by Companies
3.4 Global Interleukin 17A Sales by Companies
3.5 Global Interleukin 17A Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Interleukin 17A Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Interleukin 17A Product Type
3.8 Tier 1, Tier 2 and Tier 3 Interleukin 17A Players in Global Market
3.8.1 List of Global Tier 1 Interleukin 17A Companies
3.8.2 List of Global Tier 2 and Tier 3 Interleukin 17A Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Interleukin 17A Market Size Markets, 2021 & 2028
4.1.2 ABY-035
4.1.3 CNTO-6785
4.1.4 DLX-2882
4.1.5 Others
4.2 By Type - Global Interleukin 17A Revenue & Forecasts
4.2.1 By Type - Global Interleukin 17A Revenue, 2017-2022
4.2.2 By Type - Global Interleukin 17A Revenue, 2023-2028
4.2.3 By Type - Global Interleukin 17A Revenue Market Share, 2017-2028
4.3 By Type - Global Interleukin 17A Sales & Forecasts
4.3.1 By Type - Global Interleukin 17A Sales, 2017-2022
4.3.2 By Type - Global Interleukin 17A Sales, 2023-2028
4.3.3 By Type - Global Interleukin 17A Sales Market Share, 2017-2028
4.4 By Type - Global Interleukin 17A Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Interleukin 17A Market Size, 2021 & 2028
5.1.2 Chronic Pain
5.1.3 Liver Cancer
5.1.4 Kidney Cancer
5.1.5 Others
5.2 By Application - Global Interleukin 17A Revenue & Forecasts
5.2.1 By Application - Global Interleukin 17A Revenue, 2017-2022
5.2.2 By Application - Global Interleukin 17A Revenue, 2023-2028
5.2.3 By Application - Global Interleukin 17A Revenue Market Share, 2017-2028
5.3 By Application - Global Interleukin 17A Sales & Forecasts
5.3.1 By Application - Global Interleukin 17A Sales, 2017-2022
5.3.2 By Application - Global Interleukin 17A Sales, 2023-2028
5.3.3 By Application - Global Interleukin 17A Sales Market Share, 2017-2028
5.4 By Application - Global Interleukin 17A Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Interleukin 17A Market Size, 2021 & 2028
6.2 By Region - Global Interleukin 17A Revenue & Forecasts
6.2.1 By Region - Global Interleukin 17A Revenue, 2017-2022
6.2.2 By Region - Global Interleukin 17A Revenue, 2023-2028
6.2.3 By Region - Global Interleukin 17A Revenue Market Share, 2017-2028
6.3 By Region - Global Interleukin 17A Sales & Forecasts
6.3.1 By Region - Global Interleukin 17A Sales, 2017-2022
6.3.2 By Region - Global Interleukin 17A Sales, 2023-2028
6.3.3 By Region - Global Interleukin 17A Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Interleukin 17A Revenue, 2017-2028
6.4.2 By Country - North America Interleukin 17A Sales, 2017-2028
6.4.3 US Interleukin 17A Market Size, 2017-2028
6.4.4 Canada Interleukin 17A Market Size, 2017-2028
6.4.5 Mexico Interleukin 17A Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Interleukin 17A Revenue, 2017-2028
6.5.2 By Country - Europe Interleukin 17A Sales, 2017-2028
6.5.3 Germany Interleukin 17A Market Size, 2017-2028
6.5.4 France Interleukin 17A Market Size, 2017-2028
6.5.5 U.K. Interleukin 17A Market Size, 2017-2028
6.5.6 Italy Interleukin 17A Market Size, 2017-2028
6.5.7 Russia Interleukin 17A Market Size, 2017-2028
6.5.8 Nordic Countries Interleukin 17A Market Size, 2017-2028
6.5.9 Benelux Interleukin 17A Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Interleukin 17A Revenue, 2017-2028
6.6.2 By Region - Asia Interleukin 17A Sales, 2017-2028
6.6.3 China Interleukin 17A Market Size, 2017-2028
6.6.4 Japan Interleukin 17A Market Size, 2017-2028
6.6.5 South Korea Interleukin 17A Market Size, 2017-2028
6.6.6 Southeast Asia Interleukin 17A Market Size, 2017-2028
6.6.7 India Interleukin 17A Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Interleukin 17A Revenue, 2017-2028
6.7.2 By Country - South America Interleukin 17A Sales, 2017-2028
6.7.3 Brazil Interleukin 17A Market Size, 2017-2028
6.7.4 Argentina Interleukin 17A Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Interleukin 17A Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Interleukin 17A Sales, 2017-2028
6.8.3 Turkey Interleukin 17A Market Size, 2017-2028
6.8.4 Israel Interleukin 17A Market Size, 2017-2028
6.8.5 Saudi Arabia Interleukin 17A Market Size, 2017-2028
6.8.6 UAE Interleukin 17A Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AbbVie Inc
7.1.1 AbbVie Inc Corporate Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Interleukin 17A Major Product Offerings
7.1.4 AbbVie Inc Interleukin 17A Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Inc Key News
7.2 Abeome Corporation
7.2.1 Abeome Corporation Corporate Summary
7.2.2 Abeome Corporation Business Overview
7.2.3 Abeome Corporation Interleukin 17A Major Product Offerings
7.2.4 Abeome Corporation Interleukin 17A Sales and Revenue in Global (2017-2022)
7.2.5 Abeome Corporation Key News
7.3 Affibody AB
7.3.1 Affibody AB Corporate Summary
7.3.2 Affibody AB Business Overview
7.3.3 Affibody AB Interleukin 17A Major Product Offerings
7.3.4 Affibody AB Interleukin 17A Sales and Revenue in Global (2017-2022)
7.3.5 Affibody AB Key News
7.4 Cell Medica Limited
7.4.1 Cell Medica Limited Corporate Summary
7.4.2 Cell Medica Limited Business Overview
7.4.3 Cell Medica Limited Interleukin 17A Major Product Offerings
7.4.4 Cell Medica Limited Interleukin 17A Sales and Revenue in Global (2017-2022)
7.4.5 Cell Medica Limited Key News
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Corporate Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Interleukin 17A Major Product Offerings
7.5.4 Eli Lilly and Company Interleukin 17A Sales and Revenue in Global (2017-2022)
7.5.5 Eli Lilly and Company Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Interleukin 17A Major Product Offerings
7.6.4 Johnson & Johnson Interleukin 17A Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Merck KGaA
7.7.1 Merck KGaA Corporate Summary
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Interleukin 17A Major Product Offerings
7.7.4 Merck KGaA Interleukin 17A Sales and Revenue in Global (2017-2022)
7.7.5 Merck KGaA Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Interleukin 17A Major Product Offerings
7.8.4 Novartis AG Interleukin 17A Sales and Revenue in Global (2017-2022)
7.8.5 Novartis AG Key News
7.9 Orega Biotech SAS
7.9.1 Orega Biotech SAS Corporate Summary
7.9.2 Orega Biotech SAS Business Overview
7.9.3 Orega Biotech SAS Interleukin 17A Major Product Offerings
7.9.4 Orega Biotech SAS Interleukin 17A Sales and Revenue in Global (2017-2022)
7.9.5 Orega Biotech SAS Key News
8 GLOBAL INTERLEUKIN 17A PRODUCTION CAPACITY, ANALYSIS
8.1 Global Interleukin 17A Production Capacity, 2017-2028
8.2 Interleukin 17A Production Capacity of Key Manufacturers in Global Market
8.3 Global Interleukin 17A Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INTERLEUKIN 17A SUPPLY CHAIN ANALYSIS
10.1 Interleukin 17A Industry Value Chain
10.2 Interleukin 17A Upstream Market
10.3 Interleukin 17A Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Interleukin 17A Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Interleukin 17A in Global Market
Table 2. Top Interleukin 17A Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Interleukin 17A Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Interleukin 17A Revenue Share by Companies, 2017-2022
Table 5. Global Interleukin 17A Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Interleukin 17A Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Interleukin 17A Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Interleukin 17A Product Type
Table 9. List of Global Tier 1 Interleukin 17A Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Interleukin 17A Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Interleukin 17A Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Interleukin 17A Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Interleukin 17A Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Interleukin 17A Sales (K Pcs), 2017-2022
Table 15. By Type - Global Interleukin 17A Sales (K Pcs), 2023-2028
Table 16. By Application – Global Interleukin 17A Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Interleukin 17A Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Interleukin 17A Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Interleukin 17A Sales (K Pcs), 2017-2022
Table 20. By Application - Global Interleukin 17A Sales (K Pcs), 2023-2028
Table 21. By Region – Global Interleukin 17A Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Interleukin 17A Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Interleukin 17A Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Interleukin 17A Sales (K Pcs), 2017-2022
Table 25. By Region - Global Interleukin 17A Sales (K Pcs), 2023-2028
Table 26. By Country - North America Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Interleukin 17A Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Interleukin 17A Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Interleukin 17A Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Interleukin 17A Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Interleukin 17A Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Interleukin 17A Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Interleukin 17A Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Interleukin 17A Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Interleukin 17A Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Interleukin 17A Sales, (K Pcs), 2023-2028
Table 46. AbbVie Inc Corporate Summary
Table 47. AbbVie Inc Interleukin 17A Product Offerings
Table 48. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Abeome Corporation Corporate Summary
Table 50. Abeome Corporation Interleukin 17A Product Offerings
Table 51. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Affibody AB Corporate Summary
Table 53. Affibody AB Interleukin 17A Product Offerings
Table 54. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Cell Medica Limited Corporate Summary
Table 56. Cell Medica Limited Interleukin 17A Product Offerings
Table 57. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Eli Lilly and Company Corporate Summary
Table 59. Eli Lilly and Company Interleukin 17A Product Offerings
Table 60. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Interleukin 17A Product Offerings
Table 63. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Merck KGaA Corporate Summary
Table 65. Merck KGaA Interleukin 17A Product Offerings
Table 66. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Novartis AG Corporate Summary
Table 68. Novartis AG Interleukin 17A Product Offerings
Table 69. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Orega Biotech SAS Corporate Summary
Table 71. Orega Biotech SAS Interleukin 17A Product Offerings
Table 72. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Interleukin 17A Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 74. Global Interleukin 17A Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Interleukin 17A Production by Region, 2017-2022 (K Pcs)
Table 76. Global Interleukin 17A Production by Region, 2023-2028 (K Pcs)
Table 77. Interleukin 17A Market Opportunities & Trends in Global Market
Table 78. Interleukin 17A Market Drivers in Global Market
Table 79. Interleukin 17A Market Restraints in Global Market
Table 80. Interleukin 17A Raw Materials
Table 81. Interleukin 17A Raw Materials Suppliers in Global Market
Table 82. Typical Interleukin 17A Downstream
Table 83. Interleukin 17A Downstream Clients in Global Market
Table 84. Interleukin 17A Distributors and Sales Agents in Global Market
Table 1. Key Players of Interleukin 17A in Global Market
Table 2. Top Interleukin 17A Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Interleukin 17A Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Interleukin 17A Revenue Share by Companies, 2017-2022
Table 5. Global Interleukin 17A Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Interleukin 17A Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Interleukin 17A Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Interleukin 17A Product Type
Table 9. List of Global Tier 1 Interleukin 17A Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Interleukin 17A Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Interleukin 17A Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Interleukin 17A Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Interleukin 17A Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Interleukin 17A Sales (K Pcs), 2017-2022
Table 15. By Type - Global Interleukin 17A Sales (K Pcs), 2023-2028
Table 16. By Application – Global Interleukin 17A Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Interleukin 17A Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Interleukin 17A Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Interleukin 17A Sales (K Pcs), 2017-2022
Table 20. By Application - Global Interleukin 17A Sales (K Pcs), 2023-2028
Table 21. By Region – Global Interleukin 17A Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Interleukin 17A Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Interleukin 17A Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Interleukin 17A Sales (K Pcs), 2017-2022
Table 25. By Region - Global Interleukin 17A Sales (K Pcs), 2023-2028
Table 26. By Country - North America Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Interleukin 17A Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Interleukin 17A Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Interleukin 17A Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Interleukin 17A Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Interleukin 17A Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Interleukin 17A Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Interleukin 17A Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Interleukin 17A Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Interleukin 17A Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Interleukin 17A Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Interleukin 17A Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Interleukin 17A Sales, (K Pcs), 2023-2028
Table 46. AbbVie Inc Corporate Summary
Table 47. AbbVie Inc Interleukin 17A Product Offerings
Table 48. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Abeome Corporation Corporate Summary
Table 50. Abeome Corporation Interleukin 17A Product Offerings
Table 51. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Affibody AB Corporate Summary
Table 53. Affibody AB Interleukin 17A Product Offerings
Table 54. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Cell Medica Limited Corporate Summary
Table 56. Cell Medica Limited Interleukin 17A Product Offerings
Table 57. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Eli Lilly and Company Corporate Summary
Table 59. Eli Lilly and Company Interleukin 17A Product Offerings
Table 60. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Interleukin 17A Product Offerings
Table 63. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Merck KGaA Corporate Summary
Table 65. Merck KGaA Interleukin 17A Product Offerings
Table 66. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Novartis AG Corporate Summary
Table 68. Novartis AG Interleukin 17A Product Offerings
Table 69. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Orega Biotech SAS Corporate Summary
Table 71. Orega Biotech SAS Interleukin 17A Product Offerings
Table 72. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Interleukin 17A Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 74. Global Interleukin 17A Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Interleukin 17A Production by Region, 2017-2022 (K Pcs)
Table 76. Global Interleukin 17A Production by Region, 2023-2028 (K Pcs)
Table 77. Interleukin 17A Market Opportunities & Trends in Global Market
Table 78. Interleukin 17A Market Drivers in Global Market
Table 79. Interleukin 17A Market Restraints in Global Market
Table 80. Interleukin 17A Raw Materials
Table 81. Interleukin 17A Raw Materials Suppliers in Global Market
Table 82. Typical Interleukin 17A Downstream
Table 83. Interleukin 17A Downstream Clients in Global Market
Table 84. Interleukin 17A Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Interleukin 17A Segment by Type
Figure 2. Interleukin 17A Segment by Application
Figure 3. Global Interleukin 17A Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Interleukin 17A Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Interleukin 17A Revenue, 2017-2028 (US$, Mn)
Figure 7. Interleukin 17A Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Interleukin 17A Revenue in 2021
Figure 9. By Type - Global Interleukin 17A Sales Market Share, 2017-2028
Figure 10. By Type - Global Interleukin 17A Revenue Market Share, 2017-2028
Figure 11. By Type - Global Interleukin 17A Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Interleukin 17A Sales Market Share, 2017-2028
Figure 13. By Application - Global Interleukin 17A Revenue Market Share, 2017-2028
Figure 14. By Application - Global Interleukin 17A Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Interleukin 17A Sales Market Share, 2017-2028
Figure 16. By Region - Global Interleukin 17A Revenue Market Share, 2017-2028
Figure 17. By Country - North America Interleukin 17A Revenue Market Share, 2017-2028
Figure 18. By Country - North America Interleukin 17A Sales Market Share, 2017-2028
Figure 19. US Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Interleukin 17A Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Interleukin 17A Sales Market Share, 2017-2028
Figure 24. Germany Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 25. France Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Interleukin 17A Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Interleukin 17A Sales Market Share, 2017-2028
Figure 33. China Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 37. India Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Interleukin 17A Revenue Market Share, 2017-2028
Figure 39. By Country - South America Interleukin 17A Sales Market Share, 2017-2028
Figure 40. Brazil Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Interleukin 17A Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Interleukin 17A Sales Market Share, 2017-2028
Figure 44. Turkey Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 48. Global Interleukin 17A Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Interleukin 17A by Region, 2021 VS 2028
Figure 50. Interleukin 17A Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Interleukin 17A Segment by Type
Figure 2. Interleukin 17A Segment by Application
Figure 3. Global Interleukin 17A Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Interleukin 17A Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Interleukin 17A Revenue, 2017-2028 (US$, Mn)
Figure 7. Interleukin 17A Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Interleukin 17A Revenue in 2021
Figure 9. By Type - Global Interleukin 17A Sales Market Share, 2017-2028
Figure 10. By Type - Global Interleukin 17A Revenue Market Share, 2017-2028
Figure 11. By Type - Global Interleukin 17A Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Interleukin 17A Sales Market Share, 2017-2028
Figure 13. By Application - Global Interleukin 17A Revenue Market Share, 2017-2028
Figure 14. By Application - Global Interleukin 17A Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Interleukin 17A Sales Market Share, 2017-2028
Figure 16. By Region - Global Interleukin 17A Revenue Market Share, 2017-2028
Figure 17. By Country - North America Interleukin 17A Revenue Market Share, 2017-2028
Figure 18. By Country - North America Interleukin 17A Sales Market Share, 2017-2028
Figure 19. US Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Interleukin 17A Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Interleukin 17A Sales Market Share, 2017-2028
Figure 24. Germany Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 25. France Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Interleukin 17A Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Interleukin 17A Sales Market Share, 2017-2028
Figure 33. China Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 37. India Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Interleukin 17A Revenue Market Share, 2017-2028
Figure 39. By Country - South America Interleukin 17A Sales Market Share, 2017-2028
Figure 40. Brazil Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Interleukin 17A Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Interleukin 17A Sales Market Share, 2017-2028
Figure 44. Turkey Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Interleukin 17A Revenue, (US$, Mn), 2017-2028
Figure 48. Global Interleukin 17A Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Interleukin 17A by Region, 2021 VS 2028
Figure 50. Interleukin 17A Industry Value Chain
Figure 51. Marketing Channels